HIGHLIGHTS
- who: Mario Detomas from the the local ethics committee of the University Hospital ofMainfranken, University of Wu00fcrzburg, Wu00fcrzburg, Germany have published the Article: Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushingu2019s Syndrome: Results From a Single Center Cohort Study, in the Journal: (JOURNAL)
- what: The aim of this retrospective monocentric study was to compare the short-term efficacy of metyrapone and osilodrostat on cortisol levels in patients with endogenous CS. Although the applied drug dosages of osilodrostat and metyrapone could not be directly compared, with this study the authors demonstrated that cortisol . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.